This October through December under the Inflation Reduction Act, Medicare will reduce the beneficiary coinsurance amount for 34 Part B prescription drugs between $1 and $618 per average dose, the Centers for Medicare & Medicaid Services announced recently.
How Will the Prescription Drug Provisions in the Inflation
Mitigating the Inflation Reduction Act's Adverse Impacts on the
Mintz IRA Update — Other Key IRA Programs and Developments: The
News ASHE
Medicare moving to reference pricing?
Inflation Reduction Act Likely To Have A Negative Financial Impact
Inflation Reduction Act's Medicare Part B and D inflation rebates
News ASHRM
A primer on Medicare Part D prescription drug rebates: Insights